Applied health research journals
​
2022
Degavre F, Kieffer S, Bol D, Dekimpe R, Desterbecq C, Pirson T, Sandu G, Tubeuf S.Searching for sustainability in health systems: Toward a multidisciplinary evaluation of mobile health innovations. Sustainability . Accepted [Impact factor: 3.251]
​
Abraham S, Cottrell D, Edginton E, Tubeuf S. Measuring health-related quality of life measures in children: lessons from a pilot study. Research in Psychotherapy: Psychopathology, Process and Outcome. Accepted [Impact factor: 0.74]
​
2021
​
Smith I, Gilberts R, Brown S, Fernandez C, Nixon J, Reynolds C, Smith C, Lear J, Sunderland L, Green C, Good eld M, Cowdell F, Hampton P, Barker A, Vargas-Palacios A, Tubeuf S. , Wittmann M. Comparison of ALitretinoin with PUVA as the  rst line
treatment in patients with severe chronic HAnd eczema (ALPHA): study protocol for a randomised controlled trial. BMJ Open, Accepted [Impact factor: 2.692]
Bryant M., Burton W. Collinson M. Farrin A. Nixon J. Stevens J. Roberts K. Foy R. Rutter H. Copsey B. Hartley S. Tubeuf S. Brown J. A cluster RCT and process evaluation of an implementation optimisation intervention to promote parental engagement enrollment and attendance in a childhood obesity prevention programme: Results of the Optimising Family Engagement in HENRY (OFTEN) trial. Trials, Accepted [Impact factor: 2.279]
​
Kessels R., Luyten J., Tubeuf S. Willingness to get vaccinated against Covid-19 and attitudes toward vaccination in general. Vaccine, 39: 4716-4722 [Impact factor: 3.143]
​
2020
​
Bricard D., Jusot F., Trannoy A., Tubeuf S. Inequality of opportunities in health and death: an investigation from birth to middle age in Great Britain. International Journal of Epidemiology, 49(5): 1739-1748 [Impact factor: 7.339]
​
Wickramasekera N. Tubeuf S. Measuring quality of life for people with common mental health problems. Journal of Mental Health, 11; 1-8. [Impact factor: 2.703]
Banse E., Bigot A., De Valkeneer CP, Lorant V., Luminet O., Nicaise P., Smith P., Tubeuf S., Wuillaume A. Quelques enseignements sur les impacts sociaux et  economiques de la stratégie de réponse à la pandémie du coronavirus en Belgique. Louvain médical, 139(05-06), 375-382.
​
Owens D., Wright-Hughes A., Graham E, Blenkiron P., Burton K., Collinson M., Farrin A, Hatcher S., Martin K., O'Dwyer J, Pembroke L., Protheroe D, Tubeuf S, House A. Effectiveness of a problem-solving therapy rather than treatment as usual for adults after self-harm: a pragmatic, feasibility, randomised controlled trial (the MIDSHIPS trial). Pilot and Feasibility Studies, 6: 119 [Impact factor: 1.76]
House A., West R., Smith C., Tubeuf S., Guthrie E., Trigwell P. The effect of a hospital liaison psychiatry service on inpatient lengths of stay: interrupted time series analysis using routinely collected NHS hospital episode statistics. BMC Psychiatry, 2020, 20:27
[Impact factor: 2.666]
Cottrell D.,Wright-Hughes A., Eisler I., Fortune S, Green J., House A., Kerfoot M., Owens D., Simic M., McLellan V., Tubeuf S., Farrin A. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an
extended follow up of pragmatic randomised controlled trial. The Lancet Journal EClinical Medicine, 2020, 18: 100246 [Impact factor: n/a, this is a new journal from The Lancet IF:59.102]
​
2019
​
Smith C., Hewison J., West R, Guthrie E., Trigwell P, Crawford M., Czoski-Murray C., Fossey M., Hulme C., Tubeuf S., House A. Liaison Psychiatry - Measurement and Evaluation of Service Types, Referral patterns and Outcomes - LP- MAESTRO:
a protocol. BMJ Open, 2019, 9 (11): p. e032179 [Impact factor: 2.376]
Murray J. Wickramasekera N. Elings M. Bragg R. Brennan C. Richardson Z. Wright J. Garcia Llorente M. Cade J. Shickle D. Tubeuf S. Elsey H. The impact of care farms on quality of life, depression and anxiety among di erent population groups: a systematic
review. Campbell Systematic Reviews. 2019; 15: e1061 [Impact factor: 4.95]
​
2018
Edginton E. Walwyn R. Twiddy M. Wright-Hughes A. Tubeuf S. Reed S. Smith A. Stubbs L. Birtwhistle J. Abraham S.J. Ellis L. Midgley N. Hughes T. Wallis P. Cottrell D. TIGA-CUB - Manualised psychoanalytic child psychotherapy versus treatment as usual for children aged 5-11 with treatment resistant conduct disorders and their primary carers: results from a randomised controlled feasibility trial. Child and Adolescent Mental Health, 2018, 30(3):167-182. [Impact factor: 0.635]
​
House A. Guthrie E. Walker A. Hewison J. Trigwell P. Brennan C. Crawford M. Czoski Murray C. Fossey M. Hulme C. Martin A. Quirk A. Tubeuf S. A programme theory for liaison mental health services in England. BMC Health Services, 18:742 [Impact factor: 1.66]
​
Bryant M. Burton W. Collinson M. Hartley S. Tubeuf S. Roberts K. Sondaal A. Farrin A. Cluster randomised controlled feasibility study of HENRY; a community based intervention aimed at reducing obesity rates in preschool children. Pilot and Feasibility Studies, 2018, 4 (118): 1-15.
​
Elsey H. Bragg R. Elings M. Brennan C. Farragher T. Tubeuf S. Gold R. Shickle D. Wickramasekera N. Richardson Z. Cade J. Murray J. Assessing the impact of care farms on quality of life and offending: a pilot study among probation service users in England in BMJ Open 8(3): e019296 [Impact Factor: 2.41]
Cottrell D. Wright-Hughes A. Collinson M. Boston P. Eisler I. Fortune S. Graham E. Green J. House A. Kerfoot M. Owens D. Saloniki E. Simic M. Tubeuf S. Farrin A. Effectiveness and cost-effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: a pragmatic randomised controlled trial. The Lancet Psychiatry, Early View [Impact Factor: 11.58]
2017​
Edginton E. Walwyn R. Burton K. Cicero R. Graham E. Tubeuf S. Twiddy M. Ellis L. Evans D. Hughes T. Midgley N. Wallis P. Wright-Hughes A. Cottrell D. TIGA-CUB: Trial on improving Inter-Generational Attachment for Children Undergoing Behaviour problems: study protocol for a randomized controlled feasibility trial. Trials, 2017, 18(1):431
Tubeuf S. Guthmuller S. Economic value of family based therapies for children and young people: what do we know? Global and Regional Health Technology Assessment, 2017, 4(1).
​
Cottrell D., Wright-Hughes A., Collinson M., Boston P., Eisler I., Fortune S., Graham E., Green J., House A., Kerfoot M., Owens D., Saloniki E., Simic M., Tubeuf S., Farrin A. A pragmatic randomised controlled trial of family therapy vs. treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention, Family Therapy (SHIFT) trial. Health Technology Assessment, Accepted [Impact Factor: 4.058]
Bryant M., Burton W., Farrin A., Nixon J., Stevens J., Cundill B., Foy R., Rutter H., Brown J., Tubeuf S., Effectiveness of an implementation optimisation intervention aimed at increasing parent engagement in HENRY, a childhood obesity prevention programme: Protocol of the ‘Optimising family engagement in HENRY (OFTEN) Study: a multi-centre, Cluster Randomised Controlled Trial. Trials, 18:40 DOI: 10.1186/s13063-016-1732-3 [Impact Factor: 1.859]
2016
Smith IL, Brown S, Nixon J, Cowdell F, Ersser S, Fernandez C, Goodfield M, Green C, Hampton P, Lear J, Smith C, Sunderland L, Tubeuf S, Wittmann M. Treatment of severe, chronic hand eczema. Results from a UK-wide survey. Clinical and Experimental Dermatology, DOI: 10.1111/ced.13015. [Impact Factor: 1.315]
2015
Wright-Hughes A, Graham E, Farrin A, Collinson M, Boston P, Eisler I, Fortune S, Green J, House A, Owens D, Simic M, Tubeuf S, Nixon J, McCabe C, Kerfoot M, Cottrell D. SHIFT. Self-Harm Intervention, Family Therapy: a randomised controlled trial of family therapy vs. treatment as usual for young people seen after second or subsequent episodes of self-harm: protocol for a randomised controlled trial. Trials 2015; 16:501 [Impact Factor: 1.859]
Tubeuf S., Yu G., Achten J., Parsons N., Rangan A., Lamb S., Costal M., Cost-effectiveness of percutaneous fixation with Kirschner wires versus locking-plate for adult patients with a dorsally displaced fracture of the distal radius from the DRAFFT trial. Bone and Joint Journal 2015; 97-B:1082–9 [Impact Factor: 2.660]
Harris E., Tiganescu A., Tubeuf S., Mackie S. L. The prediction and monitoring of toxicity with long-term systemic glucocorticoid therapy. Current Rheumatology Reports 2015. 17(6): 513 [Impact Factor: 2.976]
Wickramasekera N., Wright J., Elsey H., Murray J., Tubeuf S. Cost of crime: a systematic review. Journal of Criminal Justice 2015, 43: 218-228 [Impact Factor: 3.154]
Costa ML, Achten J, Plant C, Parsons NR, Rangan A, Tubeuf S, Yu G, Lamb S. UK DRAFFT: a randomised controlled trial of percutaneous fixation with Kirschner wires versus volar locking-plate fixation in the treatment of adult patients with a dorsally displaced fracture of the distal radius. Health Technology Assessment; 19(17) [Impact Factor: 4.058]
Tubeuf S., Willis T. A., Potrata B., Ahmed M., McKibbin M. Willingness to pay for diagnostic genetic testing for inherited retinal disease. European Journal of Human Genetics, 23: 285-291 [Impact Factor: 4.349]
​
2014
Elsey, H., Bragg, R., Elings, M., Cade, J. E., Brennan, C., Farragher, T., Tubeuf, S., Gold, R., Shickle, D., Wickramasekera, N., Richardson, Z. & Murray, J. Understanding the impacts of care farms on health and well-being of disadvantaged populations: a protocol of the Evaluating Community Orders (ECO) pilot study. British Medical Journal Open, 4(11). [Impact Factor: 2.271]
Costa M., Achten J., Parsons N., Rangan A., Tubeuf S., Lamb S. A Randomised Controlled Trial of Percutaneous Fixation with Kirschner Wires versus Volar Locking-Plate Fixation in the Treatment of Adult Patients with a Dorsally Displaced Fracture of the Distal Radius. British Medical Journal, 349:g4807 [Impact Factor: 19.967]
Tubeuf S., Edlin R., Jackson C., Shourie S., Cheater F.M., Bekker H. Cost-effectiveness of a web-based decision aid for parents deciding about MMR vaccination. British Journal of General Practice, 64(625): e493-e499 [Impact Factor: 2.741]
Collinson M., Owens D., Blenkiron P., Burton K., Graham L., Hatcher S., House A., Martin K., Pembroke L., Protheroe D., Tubeuf S., Farrin A., Study protocol - MIDSHIPS: Multicentre Intervention Designed for Self-Harm using Interpersonal Problem Solving: protocol for a randomised feasibility study. Trials, 15:163 [Impact Factor: 1.859]
2013
Jackson C., Shourie S., Cheater F.M., Bekker H.L., Edlin R., Tubeuf S., Harrison W., McAleese E., Schweiger M., Beryl B. A cluster randomised controlled trial of a web based decision aid to support parents' decisions about their child's Measles Mumps and Rubella (MMR) vaccination. Vaccine, 31(50):6003-10 [Impact Factor: 3.413]
2012
Brown J., Collinson F., Gregory W., McCabe C., Howard H., Lowe C., Potrata B., Tubeuf S., Hanlon P., McParland L., Wah T., Selby P., Hewison J., Brown J. The STAR trial protocol: A randomised multi-stage phase II/III study of Sunitinib comparing Temporary cessation with allowing continuation, at the time of maximal radiological response, in the first-line treatment of locally advanced/metastatic Renal Cancer. BMC Cancer, 12:598 [Impact Factor: 3.362]
Edlin R., Tubeuf S., Achten J., Parsons N., Costa M. Cost-effectiveness of total hip arthroplasty versus resurfacing arthroplasty in the treatment of young people: economic evaluation alongside a clinical trial. British Medical Journal Open. 2(5) [Impact Factor: 2.271]
2011
Bricard D, Jusot F, Tubeuf S. L’influence à long terme du milieu social d’origine et du tabagisme des parents sur le tabagisme en France : les résultats de l’enquête ESPS 2006. Bulletin Epidémiologique Hebdomadaire, n°8-9 [Impact Factor: 0.47]
2010
Dretzke J., Round J., Connock M., Tubeuf S., Pennant M., Fry-Smith A., Hulme C., McCabe C., Meads C.. Imatinib as adjuvant treatment following resection of KIT-positive gastrointestinal stromal tumours, Health Technology Assessment, 14 (Suppl. 2):63-70 [Impact Factor: 4.058]
Connock M, Tubeuf S, Malottki K, Uthman A, Round J, Bayliss S, Meads C, Moore D. Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis. Health Technology Assessment, 14 (Suppl. 2):1-10 [Impact Factor: 4.058]
Meads C, Round J, Tubeuf S, Moore M, Pennant M, Bayliss S. Cetuximab for the first-line treatment of metastatic colorectal cancer, Health Technology Assessment, 14 (Suppl. 1): 1-8 [Impact Factor: 4.058]
Connock M, Round J, Bayliss S, Tubeuf S, Greenheld W, Moore D. Sorafenib for advanced hepatocellular carcinoma, Health Technology Assessment, 14 (Suppl. 1): 17-21 [Impact Factor: 4.058]
Edlin R, Connock M, Tubeuf S, Round J, Fry Smith A, Hyde C, Greenheld W. Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukemia and acute myeloid leukaemia. Health Technology Assessment, 14 (Suppl. 1): 69-74 [Impact Factor: 4.058]
2009
Tubeuf S. Income-related health inequalities in France in 2004: decomposition and explanations, Revue d'Epidémiologie et de Santé Publique, 5 (57): 319 -328 [Impact Factor: 0.787]
2008 and earlier
Devaux M., Jusot F., Sermet C., Tubeuf S. Hétérogénéité sociale de déclaration de l’état de santé et mesure des inégalités de santé. Revue Française des Affaires Sociales, 1: 29-47.
Doorslaer E van, Masseria C, Koolman X, Lafortune G, Clarke P, Gerdtham U-G, Häkkinen U, Couffinhal A, Tubeuf S, Schellhorn M, Szende A, Nigenda G, Arreola H, Grasdal A, Leu R, Puffer F, Seidler E. Inequalities in access to medical care by income in developed countries. Canadian Medical Association Journal, 17, 177-183 [Impact Factor: 6.7]
Couffinhal A., Dourgnon P., Tubeuf S. Outils de mesure des inégalités : quelques débats d’actualité. Santé, Société et Solidarité (2) : 163-171